| Q36815135 | A New Year toast ... to the cardioprotective effects of alcohol |
| Q47987286 | A controlled trial of the effects of pattern of alcohol intake on serum lipid levels in regular drinkers |
| Q37864989 | A review of the relationship between coffee consumption and coronary heart disease |
| Q77853784 | ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stab |
| Q70449187 | Acute myocardial infarction in patients with normal coronary arteries after acute ethanol intoxication |
| Q68324540 | Ageing and Disease |
| Q40393987 | Alcohol Abuse and Cardiac Disease |
| Q66847449 | Alcohol Consumption and Coronary-Artery Disease |
| Q41015142 | Alcohol Use, Myocardial Infarction, Sudden Cardiac Death, and Hypertension |
| Q41015128 | Alcohol and Coronary Arteries |
| Q38544378 | Alcohol and cardiovascular diseases: where do we stand today? |
| Q35229134 | Alcohol and high-density lipoproteins |
| Q42054875 | Alcohol and ischaemic heart disease in middle aged British men. |
| Q44981422 | Alcohol and mortality in British men: explaining the U-shaped curve |
| Q70309574 | Alcohol and the heart |
| Q74348244 | Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: the role of HDL(3) cholesterol |
| Q35180241 | Alcohol consumption and risk of coronary heart disease |
| Q94322719 | Alcohol consumption and risk of coronary heart disease |
| Q36597582 | Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study |
| Q46080759 | Alcohol consumption, social support, and risk of stroke and coronary heart disease among Japanese men: the JPHC Study |
| Q38077787 | Alcohol consumption: can we safely toast to our health? |
| Q26799160 | Alcohol intake and associated risk of major cardiovascular outcomes in women compared with men: a systematic review and meta-analysis of prospective observational studies |
| Q71564645 | Alcohol intake as a risk factor for peripheral arterial disease in the general population in the Edinburgh Artery Study |
| Q38688133 | Alcohol, hypertension and the cardiovascular system: a critical appraisal |
| Q41457636 | Alcohol, ischemic heart disease, and the French paradox |
| Q34696914 | Alcohol, type of alcohol, and all-cause and coronary heart disease mortality |
| Q70114571 | Alcohol-induced hypertension: mechanisms, complications, and clinical implications |
| Q70858485 | Alcoholic beverages and myocardial infarction in young women |
| Q41422767 | Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours. |
| Q77424101 | Association between cigarette and alcohol consumption and Raynaud's phenomenon |
| Q40476525 | Beyond alcohol: Beverage consumption and cardiovascular mortality |
| Q35585968 | Beyond the French paradox: the impact of moderate beverage alcohol and wine consumption in the prevention of cardiovascular disease |
| Q40212954 | Black-white differences in plasma lipids and lipoproteins in adults: The Cincinnati lipid research clinic population study |
| Q42700115 | Blood lipids: the relationship with alcohol intake, smoking, and body weight |
| Q38653646 | Caffeine and cardiovascular health |
| Q38746072 | Cardiac abnormalities in liver cirrhosis |
| Q36284511 | Cardiovascular Effects of Caffeine: Misconceptions about caffeine use and caronary heart disease. |
| Q70156198 | Cardiovascular effects of alcohol |
| Q72046949 | Case 3—1995 three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation |
| Q40314485 | Cellular and molecular aspects of immune system aging |
| Q66699903 | Cerebral infarction and myocardial infarction |
| Q35180684 | Change in alcohol consumption and risk of death from all causes and from ischaemic heart disease |
| Q36933703 | Changing drinking pattern does not influence health perception: a longitudinal study of the atherosclerosis risk in communities study |
| Q66904521 | Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations |
| Q41630280 | Characteristics predictive of coronary heart disease in ex-smokers before they stopped smoking: Comparison with persistent smokers and nonsmokers |
| Q34402938 | Chocolate: food as medicine/medicine as food |
| Q67376119 | Chronic effects of alcohol |
| Q40261718 | Cigarette smoking, alcohol intake, and oral contraceptives: Relationships to lipids and lipoproteins in adolescent school-children |
| Q43111120 | Coffee and coronary disease |
| Q33701753 | Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study |
| Q46143860 | Coffee consumption and cause-specific mortality association with age at death and compression of mortality |
| Q30472236 | Coffee consumption in hypertensive men in older middle-age and the risk of stroke: the Honolulu Heart Program |
| Q70729272 | Commentary: alcohol, the heart, and public policy |
| Q71249788 | Consumption of coffee or tea and symptoms of anxiety |
| Q40580003 | Definite Myocardial Infarction in Auckland* |
| Q34934138 | Dietary fats and coronary heart disease pathogenesis |
| Q33614109 | Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. |
| Q34480283 | Drugs, alcohol and malabsorption |
| Q48060740 | Dyslipidemia associated with heavy alcohol use. |
| Q35229712 | Early identification of alcohol abuse: 1. Critical issues and psychosocial indicators for a composite index |
| Q35229903 | Early identification of alcohol abuse: 2: Clinical and laboratory indicators. |
| Q46550137 | Effect of aldehyde dehydrogenase-2 genotype on cardiac autonomic nervous responses to moderate alcohol ingestion. |
| Q44508742 | Effect of behavior state on caffeine's ability to alter blood pressure |
| Q34537158 | Effects of chronic ethanol intake on mobilization and excretion of cholesterol in baboons |
| Q52766101 | Epidemiological studies of chronic disease: maladjustment of observed mortality rates. |
| Q70318218 | Ethanol inhibits platelet thromboxane A2 production but has no effect on lung prostacyclin synthesis in humans |
| Q41609559 | Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: Implications for a mechanism for atherosclerosis protection |
| Q34594669 | Experimental evidence for the cardioprotective effects of red wine. |
| Q34062809 | Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine |
| Q34384030 | Factors influencing the relation between alcohol and mortality--with focus on wine |
| Q44064911 | Genetic variation in aldehyde dehydrogenase 2 and the effect of alcohol consumption on cholesterol levels |
| Q44123758 | H.D.L. cholesterol in diabetes mellitus |
| Q40257470 | High density lipoprotein levels in children of young men with ischaemic heart disease |
| Q40250660 | High-density lipoprotein cholesterol: methods and clinical significance |
| Q34699225 | High-density lipoprotein response to alcohol consumption and abstinence as an indicator of liver function in alcoholic patients. |
| Q36451263 | High-density lipoprotein, low-density lipoprotein, and coronary heart disease |
| Q71158532 | High-density-lipoprotein cholesterol and types of alcoholic beverages consumed among men and women |
| Q71319904 | Hyperlipidemia and pancreatitis |
| Q41195905 | Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity |
| Q33911138 | Is alcohol beneficial or harmful for cardioprotection? |
| Q52103833 | Ischemic and hypertensive heart disease in the aged: prognostic and therapeutic factors. |
| Q36211399 | Laboratory Markers of Ethanol Intake and Abuse: A Critical Appraisal |
| Q44621508 | Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans |
| Q45038841 | Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort |
| Q34490388 | Marital state, alcohol consumption, and liability to myocardial infarction, stroke, diabetes mellitus, or hypertension in men from Gothenburg |
| Q69890626 | Medical admissions in men: the risk among drinkers |
| Q41073320 | Medical manifestations of alcoholism in the elderly |
| Q50494160 | Moderate alcohol consumption and hearing loss: a protective effect. |
| Q33805844 | Moderate alcohol consumption: the gentle face of Janus |
| Q36903416 | Mortality associated with moderate intakes of wine, beer, or spirits. |
| Q36082620 | Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study |
| Q42200085 | Non-pharmacological approaches to the treatment of high blood pressure |
| Q71230047 | On alcohol intake and CHD |
| Q34257420 | Plasma high density lipoproteins. Metabolism and relationship to atherogenesis |
| Q33989397 | Polyphenols are medicine: Is it time to prescribe red wine for our patients? |
| Q69988980 | Psychosocial and behavioral factors differentiating past drinkers and life-long abstainers |
| Q43614836 | Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model |
| Q34487249 | Relation between consumption of alcohol and fatty acids esterifying serum cholesterol in healthy men |
| Q43687643 | Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Study |
| Q24655522 | Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits |
| Q71840783 | Secretion of high density lipoprotein by the isolated perfused alcoholic rat liver |
| Q40153901 | Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins |
| Q40178970 | Significance of High-Density Lipoprotein Cholesterol* |
| Q33686098 | The Tromsø heart study: alcoholic beverages and coronary risk factors |
| Q34722617 | The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking history |
| Q37952161 | The effect of exercise on plasma high density lipoproteins |
| Q33967998 | The health effects of moderate alcohol intake in humans: an epidemiologic review |
| Q40084818 | The interaction of alcohol and stress A review |
| Q39226517 | The pathophysiology of alcohol and acetaldehyde metabolism in the liver |
| Q40221366 | Treating lipid disorders |
| Q44513818 | Type of alcoholic beverage and first acute myocardial infarction: a case-control study in a Mediterranean country. |
| Q51564825 | Type of alcoholic beverage and risk of myocardial infarction. |
| Q77390897 | Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality |
| Q33606763 | Wake up and smell the coffee. Caffeine, coffee, and the medical consequences |
| Q41655295 | Wine and mortality |
| Q35544944 | Wine and resveratrol: mechanisms of cancer prevention? |
| Q41591057 | Wine as a biological fluid: history, production, and role in disease prevention |
| Q33770492 | Wine, beer and spirits and the risk of myocardial infarction: a systematic review |
| Q59696608 | Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis |
| Q54674341 | [Wine and heart] |